State Street Corp Revolution Medicines, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, State Street Corp holds 5,279,584 shares of RVMD stock, worth $229 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,279,584
Previous 5,071,068 4.11%
Holding current value
$229 Million
Previous $197 Million 21.55%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$36.92 - $47.94 $7.7 Million - $10 Million
208,516 Added 4.11%
5,279,584 $239 Million
Q2 2024

Aug 14, 2024
SELL
$30.14 - $40.68 $9.49 Million - $12.8 Million
-314,952 Reduced 5.85%
5,071,068 $197 Million
Q1 2024

May 15, 2024
SELL
$26.56 - $33.55 $23 Million - $29.1 Million
-867,341 Reduced 13.87%
5,386,020 $174 Million
Q4 2023

Feb 14, 2024
BUY
$18.35 - $34.12 $43.8 Million - $81.4 Million
2,385,751 Added 61.69%
6,253,361 $179 Million
Q3 2023

Nov 14, 2023
SELL
$25.17 - $35.05 $22.1 Million - $30.7 Million
-876,639 Reduced 18.48%
3,867,610 $107 Million
Q2 2023

Aug 14, 2023
SELL
$20.28 - $27.0 $1.36 Million - $1.81 Million
-67,182 Reduced 1.4%
4,744,249 $127 Million
Q1 2023

May 15, 2023
BUY
$20.76 - $30.09 $21.4 Million - $31 Million
1,030,420 Added 27.25%
4,811,431 $104 Million
Q4 2022

Feb 14, 2023
SELL
$17.68 - $25.53 $9.39 Million - $13.6 Million
-531,123 Reduced 12.32%
3,781,011 $90.1 Million
Q3 2022

Nov 15, 2022
BUY
$17.46 - $26.0 $21.3 Million - $31.6 Million
1,217,152 Added 39.33%
4,312,134 $85 Million
Q2 2022

Aug 15, 2022
BUY
$14.54 - $27.17 $3.66 Million - $6.83 Million
251,505 Added 8.84%
3,094,982 $60.3 Million
Q1 2022

May 16, 2022
BUY
$17.31 - $26.4 $1.54 Million - $2.35 Million
88,844 Added 3.23%
2,843,477 $72.5 Million
Q4 2021

Feb 14, 2022
SELL
$24.35 - $33.7 $1.33 Million - $1.84 Million
-54,539 Reduced 1.94%
2,754,633 $69.3 Million
Q3 2021

Nov 15, 2021
BUY
$23.95 - $33.41 $11 Million - $15.4 Million
460,582 Added 19.61%
2,809,172 $77.3 Million
Q2 2021

Aug 16, 2021
BUY
$29.0 - $47.44 $16.5 Million - $27.1 Million
570,410 Added 32.08%
2,348,590 $74.5 Million
Q1 2021

May 17, 2021
SELL
$37.21 - $54.43 $481,943 - $704,977
-12,952 Reduced 0.72%
1,778,180 $81.6 Million
Q4 2020

Feb 16, 2021
BUY
$30.19 - $45.49 $21.7 Million - $32.8 Million
720,230 Added 67.25%
1,791,132 $70.9 Million
Q3 2020

Nov 10, 2020
BUY
$22.61 - $34.8 $18.3 Million - $28.1 Million
808,613 Added 308.29%
1,070,902 $37.3 Million
Q2 2020

Aug 14, 2020
BUY
$19.65 - $39.34 $507,716 - $1.02 Million
25,838 Added 10.93%
262,289 $8.28 Million
Q1 2020

May 11, 2020
BUY
$20.0 - $34.08 $4.73 Million - $8.06 Million
236,451 New
236,451 $5.18 Million

Others Institutions Holding RVMD

# of Institutions
266
Shares Held
161M
Call Options Held
260K
Put Options Held
620K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email